You are here

Eli Lilly

Two-Year Data Comparing Cardiovascular Events with Linagliptin and the Sulfonylurea, Glimepiride, Presented as Late-Breaking Poster at ADA

Yahoo/PR NewsWire

Sat, 06/25/11 - 08:42 pm

Boehringer Ingelheim

New Phase III Data and Pooled Analysis for Linagliptin Show Improved Blood Sugar Control in Adults With Type 2 Diabetes When Used Alone and With Metformin

Yahoo/PR NewsWire

Sat, 06/25/11 - 12:03 pm

Boehringer Ingelheim

Lilly CEO: Ease immigration laws to boost innovation

Fierce Biotech

Thu, 06/23/11 - 11:09 am

John Lechleiter

EU approves Lilly's weekly diabetes drug Bydureon

Yahoo/AP

Tue, 06/21/11 - 10:42 am

Patent Cliff Losses Mean Eli Lilly Must Acquire or Be Acquired

BNET Pharma

Mon, 06/20/11 - 11:08 am

When Two Cancer Drugs Are Better Than One

Bloomberg Businessweek

Fri, 06/17/11 - 10:17 am

Bristol-Myers Squibb

Eli Lilly Offers Remedies in EU Review of Janssen Deal

Bloomberg

Fri, 06/17/11 - 09:30 am

Janssen Pharmaceuticals

Off a Cliff: $100 Billion in Revenues Will Disappear From Drug Business by 2013

BNET Pharma

Thu, 06/16/11 - 12:29 pm

Bristol-Myers Squibb

Boehringer Ingelheim and Lilly's New Type 2 Diabetes Treatment Tradjenta (Linagliptin) Tablets for Adults Now Available in U.S. Pharmacies

Pharma Live

Thu, 06/16/11 - 11:25 am

Boehringer Ingelheim

type 2 diabetes

Risk-Reward Balanced at Incyte

Yahoo/Zacks.com

Wed, 06/15/11 - 09:26 pm

Eli Lilly insulin brand paves way for hike in imported drug prices (in India)

Economic Times, India

Sat, 06/11/11 - 12:29 pm

District court denies preliminary injunction against drugmaker Eli Lilly in Amylin litigation

Yahoo/AP

Wed, 06/8/11 - 06:48 pm

New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening

Yahoo/PR NewsWire

Sun, 06/5/11 - 10:41 am

non-small cell lung cancer

Big-Pharma Drugs to Dominate Cancer Event

Barron's

Fri, 06/3/11 - 06:48 pm

Bristol-Myers Squibb

Ariad Pharmaceuticals

How Lilly Blundered With Amylin: Kliff Explains

Pharmalot

Thu, 06/2/11 - 10:31 am

Drugmakers Face Patent Cliff Generics

Yahoo/InvestorsBusinessDaily

Wed, 06/1/11 - 07:46 am

Bristol-Myers Squibb

Teva Pharmaceuticals

Abbott Laboratories

Eli Lilly Dividend, Cash Flow Safe Despite Patent Cliff: Barclays

Barron's

Sat, 05/28/11 - 12:10 pm

A Hidden Reason Why Eli Lilly's Earnings Are Outstanding

Motley Fool

Sat, 05/28/11 - 12:07 pm

A Hidden Reason Why Eli Lilly's Earnings Are Outstanding

Motley Fool

Fri, 05/27/11 - 10:51 am

It May Be Time for Amylin and Lilly to Head to Divorce Court

Seeking Alpha

Fri, 05/27/11 - 10:50 am

restraining order

Bristol-Myers Squibb

Lexicon Pharmaceuticals

Pages